These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 9882558

  • 1. Cellular mechanisms of diabetic vascular hypertrophy.
    Vranes D, Cooper ME, Dilley RJ.
    Microvasc Res; 1999 Jan; 57(1):8-18. PubMed ID: 9882558
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tranilast reduces mesenteric vascular collagen deposition and chymase-positive mast cells in experimental diabetes.
    Jones SE, Gilbert RE, Kelly DJ.
    J Diabetes Complications; 2004 Jan; 18(5):309-15. PubMed ID: 15337505
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes.
    Gilbert RE, Rumble JR, Cao Z, Cox AJ, van Eeden P, Allen TJ, Kelly DJ, Cooper ME.
    Circ Res; 2000 Feb 04; 86(2):158-65. PubMed ID: 10666411
    [Abstract] [Full Text] [Related]

  • 7. Reduction of endothelial and smooth muscle density in the corpora cavernosa of the streptozotocin induced diabetic rat.
    Burchardt T, Burchardt M, Karden J, Buttyan R, Shabsigh A, de la Taille A, Ng PY, Anastasiadis AG, Shabsigh R.
    J Urol; 2000 Nov 04; 164(5):1807-11. PubMed ID: 11025774
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diabetes induces Na/H exchange activity and hypertrophy of rat mesenteric but not basilar arteries.
    Dilley RJ, Farrelly CA, Allen TJ, Jandeleit-Dahm K, Cooper ME, Morahan G, Little PJ.
    Diabetes Res Clin Pract; 2005 Dec 04; 70(3):201-8. PubMed ID: 15949863
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition.
    Cooper ME, Rumble J, Komers R, Du HC, Jandeleit K, Chou ST.
    Diabetes; 1994 Oct 04; 43(10):1221-8. PubMed ID: 7926292
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Human endothelial cells are defective in diabetic vascular disease.
    Sank A, Wei D, Reid J, Ertl D, Nimni M, Weaver F, Yellin A, Tuan TL.
    J Surg Res; 1994 Dec 04; 57(6):647-53. PubMed ID: 7996840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.